ALFA Filings
Every announcement, straight from the exchange
Every Windlas Biotech other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
This quarterly shareholding pattern statement for Windlas Biotech Ltd, covering the period ended September 30, 2026, provides the company's equity ownership breakdown.
Windlas Biotech submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms regulatory compliance with no material deviations noted.
Windlas Biotech Ltd submitted its quarterly certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar confirmed no physical shares exist and no dematerialization requests were received during the quarter. This is a routine administrative compliance filing with no material impact on operations.